Quest Diagnostics 在第四季度收益超出预期后，主要投资者增加了股份。 Quest Diagnostics saw increased stakes by major investors after beating Q4 earnings expectations.

澳大利亚投资公司UniSuper和三菱UFJ资产管理公司通过购买更多的股票,增加了其在医学测试公司 " 调查诊断 " 中的股份。 Australian investment firm UniSuper and Mitsubishi UFJ Asset Management increased their stakes in Quest Diagnostics, a medical testing company, by buying more shares. Quest Diagnostics 第四季度表现强劲，超出分析师预期，每股收益为 2.23 美元。 Quest Diagnostics beat analysts' expectations with a strong Q4, reporting earnings per share of $2.23. 分析员预测本年度将出现9.7 EPS。 Analysts predict 9.7 EPS for the current year. 该公司的市场上限为185.6亿美元,“Moderate Buy”评级为178.38美元目标价格。 The company has a market cap of $18.56 billion and a "Moderate Buy" rating with a $178.38 target price.